VolitionRX Ltd (VNRX) is currently exhibiting a high-squeeze setup, according to recent data. As of August 27, 2026, the borrow fee for VNRX has spiked to 21.7%, indicating significant difficulty in sourcing shares for shorting. Official short interest data as of the August 14, 2026 settlement shows 683.9K shares short, representing 5.0% of the total shares outstanding. This is a notable increase from the 3.9% reported in the previous July 31, 2026 settlement. While the structure is primed for a squeeze, market volume has not yet confirmed a breakout. Investors should monitor the borrow fee closely, as the company's limited cash runway and high borrow costs create a volatile environment for existing short positions.
Signal data sourced from CurvedTrading. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.